UCDAI and disease history to assess for factors leading to elimination diets trial and medica- tion compliance during diet trial. Results: At the end of the study, 142 patients had completed the survey. Patient demographics are described in table 1. A total of 67% of patients were on or had tried diets in the past, with 39% trying multiple diets. Medication compliance did not vary between those who had and had not tried diets (p=0.67). Low residue was the most common diet (71%), followed by lactose free (13%), and gluten free (6%). Female patients were more likely to have tried an ED compared to males (63.8 vs. 36.2%, p=0.03), however race, age, education, income level, disease type, and disease duration had no association with an ED trial. Patients who had tried ED had significantly lower mean SIBDQ scores (46.6 vs. 57.2, p=0.001) and higher mean HBI/UCDAI (2.8 vs 1.3, p=0.02) than those that had not tried a diet. While on a diet, 51% of patients reported feeling a little better, and 18% reported feeling a lot better. Medication compliance was not effected by ED trial. Conclusion: Female patients, patients with lower SIBDQ scores, and patients with higher disease activity scores were more likely to have tried an ED. Patients who tried ED commonly report improvement of symptoms while on ED, however this this did not affect medication compliance. Overall the majority of IBD patients, particularly those doing poorly, have tried some form of ED which fortunately does not appear to affect medication compli- ance. Table 1 Tu1262 Internal Locus of Control and Increased Self-Efficacy Are Associated With Higher Quality of Life in Patients With Inflammatory Bowel Disease Guruprasad D. Jambaulikar, Joy Lee, Mahoussi Aholoukpe, Miguel Regueiro, David A. Schwartz, Leyla J. Ghazi, Seema Patil, Mark Flasar, Kathleen Tracy, Raymond Cross Objectives: The objectives of this study were to examine demographic and clinical characteris- tics associated with locus of control (LOC) and self-efficacy (SES) and to determine of the impact of LOC and self-efficacy on quality of life (QoL) in patients with inflammatory bowel disease. Methods: Patients with Crohn's disease (CD) and ulcerative colitis (UC) were recruited as part of an ongoing randomized, controlled trial of which the specific aim is to evaluate the effectiveness of TELEmedicine for patients with Inflammatory Bowel Disease (TELE-IBD) over a one year period. At the baseline visit, information on demographics and clinical history, disease activity, QoL, SES, and LOC is collected. LOC is assessed using the Rotter's LOC scale. SES is assessed using the General Self-Efficacy Scale. Lower LOC and higher SES scores represent internal LOC and higher self-efficacy respectively. We classified internal LOC as less than the mean LOC score and higher self-efficacy as greater than the mean SES score. The association between demographic and clinical variables and LOC and SES and the association between LOC and SES and QoL were assessed. Results: Complete baseline data was available for 148 participants. 59% were women, 92% were Caucasian, and 72% had CD. The average age was 38.2+/-12.0 years and average disease duration was 11.1+/-9.0 years. 75% of participants had flared within one year of the baseline visit. However, 68% and 64% of UC and CD patients were in remission at baseline. 44% of patients with CD had non-stricturing, non-penetrating disease behavior and 34% had perianal involvement. Mean LOC scores were 9.8+/-3.5. Female gender (p=0.016) and non-stricturing, non-penetrating disease behavior (p=0.064) were associated with external LOC. Participants with internal LOC had significantly higher QoL scores across all sub-scales than patients with external LOC (see Table 1). No variables were associated with higher SES scores. However, patients with high SES scores had significantly increased QoL scores across all sub-scales (see Table 2). Conclusions: Female gender and non-stricturing, non-penetrating disease behavior in patients with CD are associated with external LOC. Internal LOC and higher self-efficacy are associated with significantly increased QoL scores across all sub- scales. Future studies are ongoing to determine if interventions such as TELE-IBD can change LOC from external to internal and to improve self-efficacy. Further, TELE-IBD will determine if external LOC and decreased self-efficacy modify the effect of telemedicine on clinical out- comes. Association between LOC and QoL p<0.05 for all sub-scales Association between SES and QoL p<0.05 for all sub-scales S-841 AGA Abstracts Tu1263 Transitional Care in Inflammatory Bowel Disease: A Single Center Experience Yulia Ron, Anat Yerushalmy-Feler, Ayala Nachum, Iris Dotan, Shlomi Cohen Introduction: Inflammatory bowel disease (IBD) is a chronic disease with a natural history of relapse and remission. Approximately 25% of IBD patients are diagnosed before the age of 16 years. The approach to investigation and treatment, service provision and ideology of care differ between children and adults. This calls for an organized and planned transition process. Yet, transition clinics are still scarce. A transition adolescent-young adult IBD clinic was established in our tertiary referral center in 2013. Patients are seen conjointly by pediatric and an adult gastroenterologists, an IBD nurse, dietitian and a psychologist. The aim of this study is to quantitatively describe the importance of the transitional care in IBD. Methods: We conducted retrospective review of all patient files visiting the transitional clinic. A self-efficacy questionnaire (the "IBD-yourself") was used to assess patients' skills for self- management of chronic conditions, their self-advocacy, and their healthcare utilization before and after joining our clinic. In general, each question obtained a 4 point score (1 - Yes, definitely and 4 - No, definitely not). We have also compared their self-efficacy according to disease extent, disease duration and therapeutic strategy. Results: Twenty one patients visited the clinic in January/2013-November/2014. The vast majority (20/21) had Crohn's disease, the average age was 19.4±2.1 (range 17-27) years, and average disease duration 4.9±3 (range 0.67-10) years. Ten patients (48%) were treated with immunomodulators, 6 patients (29%) with 5ASA, 4 patients (19%) with anti TNF medications and 1 patient was not treated. The transitional process, completed by 15 (11 males) included an average of 3-4 meetings over an average of 7±4.1 months. Significantly higher self efficacy score after completing the transition compared to before starting it was noticed in the following domains: knowledge of IBD (P=0.01), of diagnostic tests (P=0.0004), of medication use (P=0.003), self management in an outpatient clinic (P=0.016), understanding the transition process (P= 0.0001) and self readiness for transition (P=0.013). A positive correlation between number of meeting and coping with IBD (r=0.56, p=0.029) was noticed as well. No correlation was found between disease extent, disease duration, therapeutic strategy and change of readiness during the transition. Conclusion: An organized adolescent-young adult IBD transition clinic significantly contributes to higher cores in self management of IBD. The transition process is a major part o a successful transfer to the adult gastroenterologist and should be imple- mented in IBD Centers. Tu1264 Intolerance of Uncertainty and Quality of Life in Patients With Ulcerative Colitis Chantal Li, Elizabeth Kmiotek, Joanne M. Stempak, Anitha Kumaaravel, Tae Hart, Mark S. Silverberg, Robert G. Maunder Background: Patients with ulcerative colitis (UC) are often concerned about the uncertain nature of the disease, but little is known about how intolerance of uncertainty affects health- related quality of life (HRQOL). Methods: Two hundred and fifty-six surveys were distributed to UC patients at Mount Sinai Hospital, of which 224 surveys were completed and included in the analysis. The survey measured demographic data, intolerance of uncertainty, using the abbreviated Intolerance of Uncertainty Scale (IUS-12), and HRQOL, using the short Inflammatory Bowel Disease Questionnaire (SIBDQ). Disease activity was classified by patient self-report in four categories: in remission with less than one flare yearly, in remission with one flare per year, in remission with more than one flare yearly, and currently experiencing a flare. Results: Better HRQOL was correlated with increasing age (r = .181, p = .007) and increasing income (χ 2 (3) = 8.047, p = .045), and disease activity was negatively and strongly associated with HRQOL (χ 2 (3) =74.604, p <.01). There were no differences in HRQOL for gender, marital status, education, age of diagnosis, greater extent of disease, and years since UC diagnosis. Intolerance of uncertainty was negatively correlated with HRQOL (r = -.305, p <.001). Intolerance of uncertainty (F = 1.683, p =.011) remained significantly associated with HRQOL after controlling for disease activity (F = 33.592, p < .001). Conclusion: UC patients' intolerance of uncertainty negatively influences HRQOL, even after controlling for disease activity. Uncertainty is commonly an irreducible aspect of living with UC; however, improving tolerance of uncertainty may be more amenable to intervention. Identifying methods of improving tolerance of uncertainty in order to improve HQROL merits investiga- tion. Key Words: Intolerance of uncertainty, ulcerative colitis, quality of life, disease course activity Tu1265 Inflammatory Bowel Disease Patient's Participation in Therapeutic Decision Making Stephan R. Vavricka, Gerhard Rogler, Ekaterina Safroneeva, Alain Schoepfer Background: Non-adherence to medical treatment in patients with inflammatory bowel disease (IBD) is a matter of a grave concern. Active participation in therapeutic decision making, as one of the aspects of patient empowerment, has potential to increase adherence to therapy. However, data from large studies on patients' participation in therapeutic decision making in IBD is scarce. Aims: we aimed to evaluate the patients' role in therapeutic decision making. Methods: A paper-based 15-item questionnaire was developed by IBD experts and sent to 2,100 members of the Swiss Association of IBD patients in September, 2014. In addition to patient baseline characteristics, the patients were asked about their experience in regards to developing a therapeutic concept together with their treating gastroenterologist. Results: A total of 824/2,100 (39.2%) adult IBD patients sent back the completed question- naires. Of these patients, 66% were female, 57% had CD, 41% had UC, and 2% had unclassified IBD. The age distribution was as follows: 31% were ≤ 40 years, 47% were between 41-60 years, and 22% were > 60 years old. When being asked "How actively were you involved in therapy decisions?" patients chose the following options: 50% told that their gastroenterologist proposed one particular therapy regimen which they followed, 23% told that their gastroenterologists provided them with several therapeutic options of which they chose one, 8% of patients told that they read about various therapeutic options on the AGA Abstracts